Skip Page Header

Home > Naltrexone and acamprosate best suited to different alcohol treatment goals.

[Drug and Alcohol Findings] (2016) Naltrexone and acamprosate best suited to different alcohol treatment goals. London: Drug and Alcohol Findings. Drug and Alcohol Findings Bulletin (13 December 2016) 3 p.

[img]
Preview
PDF (Metaanalysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?)
130kB

URL: http://findings.org.uk/PHP/dl.php?file=Maisel_NC_1...

Naltrexone and acamprosate both modestly curtail drinking among alcohol-dependent patients, but which is best in which circumstances and for which treatment goals? To find out this review compared the medications’ performance when separately benchmarked against a placebo, bringing to bear much more data than is available from the few trials which directly compared the two drugs.

Key points From summary and commentary
• The medications naltrexone and acamprosate both modestly curtail drinking among alcohol-dependent patients, but it is unclear which is best in which circumstances and for which treatment goals.
• Rather than confining itself to direct comparisons of the drugs, the featured analysis addressed these issues by comparing the two medications’ performance when separately benchmarked against a placebo.
• Findings suggested naltrexone is best for patients who want to control their heavy drinking, acamprosate for those seeking abstinence. Both seem more effective when patients have detoxified and/or stopped drinking in the run-up to treatment.


Repository Staff Only: item control page